Vitamin B2 Intake and the Risk of Colorectal Cancer: a Meta-Analysis of Observational Studies

  • Liu, Yan (Department of Public Health, Shantou University Medical College) ;
  • Yu, Qiu-Yan (Department of Public Health, Shantou University Medical College) ;
  • Zhu, Zhen-Li (Department of Public Health, Shantou University Medical College) ;
  • Tang, Ping-Yi (School of Business, University of South Australia) ;
  • Li, Ke (Department of Public Health, Shantou University Medical College)
  • Published : 2015.03.04


Background: A systematic review and meta-analysis of observational studies evaluated the association of intake of vitamin B2 with the incidence of colorectal cancer. Materials and Methods: Relevant studies were identified in MEDLINE via PubMed (published up to April 2014). We extracted data from articles on vitamin B2 and used multivariable-adjusted odds ratio (OR) and a random-effects model for analysis. Results: We found 8 articles meeting the inclusion criteria (4 of cohort studies and 4 of case-control studies) and a total of 7,750 colorectal cancer cases were included in this meta-analysis. The multivariable-adjusted OR for pooled studies for the association of the highest versus lowest vitamin B2 intake and the risk of colorectal cancer was 0.83 (95% confidence interval [95%CI]:0.75,0.91). We performed a sensitivity analysis for vitamin B2. If we omitted the study by Vecchia et al., the pooled OR was 0.86 (95%CI, 0.77,0.96). Conclusions: This is the first meta-analysis to study links between vitamin B2 and colorectal cancer. We found vitamin B2 intake was inversely associated with risk of colorectal cancer. However, further research and large sample studies need to be conducted to better validate the result.


  1. Ainiwaer J, Tuerhong A, Hasim A, et al (2013). Association of the plasma riboflavin levels and riboflavin transporter (C20orf54) gene statuses in Kazak esophageal squamous cell carcinoma patients. Mol Biol Rep 40, 3769-75.
  2. Bareford L M, Avaritt B R, Ghandehari H, Nan A, Swaan P W (2013). Riboflavin-targeted polymer conjugates for breast tumor delivery. Pharm Res, 30, 1799-812.
  3. Bassett J K, Severi G, Hodge A M, et al (2013). Dietary intake of B vitamins and methionine and colorectal cancer risk. Nutr Cancer, 65, 659-67.
  4. Begg C B, and Mazumdar M (1994). Operating characteristics of a rank correlation test for publication bias. Biometrics, 1088-101
  5. Center M M, Jemal A, Smith R A, Ward E (2009). Worldwide variations in colorectal cancer. CA: Cancer J Clin, 59, 366-78
  6. Chaves Neto A H, Pelizzaro-Rocha K J, Fernandes M N, Ferreira- Halder C V (2014). Antitumor activity of irradiated riboflavin on human renal carcinoma cell line 786-O. Tumour Biol.
  7. Christensen H. N. (1993). Riboflavin can protect tissue from oxidative injury. Nutr Rev, 51, 149-150.
  8. Colombo B, Saraceno L, Comi G (2014). Riboflavin and migraine: the bridge over troubled mitochondria. Neurol Sci, 35, 141-4.
  9. de Vogel S, Dindore V, van Engeland M, et al (2008). Dietary folate methionine riboflavin and vitamin B-6 and risk of sporadic colorectal cancer. J Nutr, 138, 2372-8.
  10. DerSimonian R, Laird N (1986). Meta-analysis in clinical trials. Controlled clinical trials, 7, 177-88.
  11. Duval S, Tweedie R (2000a). A nonparametric “trim and fill” method of accounting for publication bias in meta-analysis. J Am Statistical Association, 95, 89-98.
  12. Duval S, Tweedie R. (2000b). Trim and fill: A simple funnel plot-based method of testing and adjusting for publication bias in meta analysis. Biometrics, 56, 455-463.
  13. Eli M, Li DS, Zhang WW, et al (2012). Decreased blood riboflavin levels are correlated with defective expression of RFT2 gene in gastric cancer. World J Gastroenterol, 18, 3112-8.
  14. Greenland S (1987). Quantitative methods in the review of epidemiologic literature. Epidemiol Rev, 9, 1-30
  15. Higgins J (2008). Green S. Cochrane handbook for systematic reviews of interventions version 5.1. 0.
  16. Jedrychowski W, Steindorf K, Popiela T, et al (2001). Risk of colorectal cancer from alcohol consumption at lower vitamin intakes. A hospital-based case-control study in Poland. Rev Environ Health, 16, 213-222
  17. JPT CHH, Green S (2011). Cochrane handbook for systematic reviews of interventions version 5.1. 0 [updated March 2011]. The Cochrane Collaboration.
  18. La Vecchia C, Braga C, Negri E, et al (1997). Intake of selected micronutrients and risk of colorectal cancer. Int J Cancer, 73, 525-30<525::AID-IJC12>3.0.CO;2-8
  19. Ma E, Iwasaki M, Kobayashi M, et al (2009). Dietary intake of folate vitamin B2 vitamin B6 vitamin B12 genetic polymorphism of related enzymes and risk of breast cancer: a case-control study in Japan. Nutr Cancer, 61, 447-456.
  20. Ma JQ, Kurban S, Zhao JD, Li QZ, Hasimu A (2014). Epigenetic regulation of human riboflavin transporter 2 (hRFT2) in cervical cancers from Uighur women. Asian Pac J Cancer Prev, 15, 2485-9
  21. Midttun O, Townsend MK, Nygard O, et al (2014). Most blood biomarkers related to vitamin status one-carbon metabolism and the kynurenine pathway show adequate preanalytical stability and within-person reproducibility to allow assessment of exposure or nutritional status in healthy women and cardiovascular patients. J Nutr, 144, 784-790.
  22. Nolting A, Perleth M, Langer G, et al (2012). [GRADE guidelines: 5. Rating the quality of evidence: publication bias]. Z Evid Fortbild Qual Gesundhwes, 106, 670-6.
  23. O'Brien HL, Hershey AD (2010). Vitamins and paediatric migraine: Riboflavin as a preventative medication. Cephalalgia, 30, 1417-18.
  24. Peters JL, Sutton AJ, Jones DR, Abrams KR, Rushton L (2008). Contour-enhanced meta-analysis funnel plots help distinguish publication bias from other causes of asymmetry. J Clin Epidemiol, 61, 991-6
  25. Podorozhnyi PG, Vdovichenko VI, Rozanov EM, et al (1990). Vitamin deficiency in patients with ischemic heart disease. Vrach Delo, 9, 18-19 (in Russian).
  26. Powers HJ (2003). Riboflavin (vitamin B-2) and health. Am J Clin Nutr, 77, 1352-60
  27. Powers HJ (2005). Interaction among folate riboflavin genotype and cancer with reference to colorectal and cervical cancer. J Nutr, 135, 2960-66
  28. Roe DA (1991). Riboflavin deficiency: mucocutaneous signs of acute and chronic deficiency. Semin Dermatol, 10, 293-5
  29. Shin A, Li H, Shu XO, et al (2006). Dietary intake of calcium fiber and other micronutrients in relation to colorectal cancer risk: Results from the Shanghai Women's Health Study. Int J Cancer, 119, 2938-42.
  30. Shrubsole MJ, Yang G, Gao YT, et al (2009). Dietary B vitamin and methionine intakes and plasma folate are not associated with colorectal cancer risk in Chinese women. Cancer Epidemiol Biomarkers Prev, 18, 1003-6.
  31. Siegel R, Naishadham D, Jemal A (2013). Cancer statistics 2013. CA: Cancer J Clin, 63, 11-30
  32. Song F, Gilbody S. (1998). Bias in meta-analysis detected by a simple graphical test. Increase in studies of publication bias coincided with increasing use of meta-analysis. BMJ, 316, 471.
  33. Stroup DF, Berlin JA, Morton SC, et al (2000). Meta-analysis of observational studies in epidemiology: a proposal for reporting. JAMA, 283, 2008-12
  34. van Lee L, Heyworth J, McNaughton S, et al (2011). Selected dietary micronutrients and the risk of right- and left-sided colorectal cancers: a case-control study in Western Australia. Ann Epidemiol, 21, 170-7.
  35. Wells G, Shea B, O'connell D, et al (2000). The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses.
  36. Yang HT, Chao PC, Yin MC (2013). Riboflavin at high doses enhances lung cancer cell proliferation invasion and migration. J Food Sci, 78, 343-9.
  37. Yang HT, Chao PC, Yin MC (2013). Riboflavin at high doses enhances lung cancer cell proliferation invasion and migration. J Food Sci, 78, 343-9.
  38. Zhang SM, Moore SC, Lin J, et al (2006). Folate vitamin B6 multivitamin supplements and colorectal cancer risk in women. Am J Epidemiol, 163, 108-115
  39. Zschabitz S, Cheng TY, Neuhouser ML, et al (2013). B vitamin intakes and incidence of colorectal cancer: results from the Women's Health Initiative Observational Study cohort. Am J Clin Nutr, 97, 332-43.

Cited by

  1. Ocoxin® oral solution slows down tumor growth in an experimental model of colorectal cancer metastasis to the liver in Balb/c mice vol.35, pp.3, 2015,
  2. Sensitizes Cancer Cells to Vitamin-C-Induced Cell Death via Modulation of Akt and Bad Phosphorylation vol.63, pp.30, 2015,
  3. Dietary vitamin B2 intake and breast cancer risk: a systematic review and meta-analysis vol.295, pp.3, 2017,
  4. Vitamin B2 intake reduces the risk for colorectal cancer: a dose–response analysis pp.1436-6215, 2018,